Investment
Bright Ventures led a $2 million seed round for Omabit, an AI platform that helps life science companies analyze fragmented scientific evidence for drug development, clinical research and regulatory engagement. This marks Bright Ventures leading a seed round (its usual posture is participating).
Omabit